[Federal Register Volume 82, Number 177 (Thursday, September 14, 2017)]
[Pages 43237-43238]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-19497]



Centers for Disease Control and Prevention

Advisory Committee on Immunization Practices

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

[[Page 43238]]

ACTION: Notice of meeting.


SUMMARY: In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act, the Centers for Disease Control and Prevention (CDC) 
announces the following meeting of the Advisory Committee on 
Immunization Practices (ACIP).
    This meeting is open to the public, limited only by the space 
available. Time will be available for public comment. The public is 
welcome to submit written comments in advance of the meeting. Comments 
should be submitted in writing by email to the contact person listed 
below. The deadline for receipt is October 11, 2017. Written comments 
must include full name, address, organizational affiliation, email 
address of the speaker, topic being addressed and specific comments. 
Written comments must not exceed one single-spaced typed page with 1-
inch margins containing all items above. Only those written comments 
received 10 business days in advance of the meeting will be included in 
the official record of the meeting. Public comments made in attendance 
must be no longer than 3 minutes and the person giving comments must 
attend the public comment session at the start time listed on the 
agenda. Time for public comments may start before the time indicated on 
the agenda. The meeting will be webcast live via the World Wide Web; 
for instructions and more information on ACIP please visit the ACIP Web 
site: http://www.cdc.gov/vaccines/acip/index.html.

DATES: The meeting will be held on October 25, 2017, 8:00 a.m. to 6:00 
p.m., EDT, and October 26, 2017 8:00 a.m. to 3:15 p.m. EDT.

ADDRESSES: 1600 Clifton Road NE., Atlanta, GA 30329, CDC, Tom Harkin 
Global Communications Center, Kent `Oz' Nelson Auditorium.

Management Specialist, CDC, NCIRD; email: [email protected].

    Purpose: The committee is charged with advising the Director, CDC, 
on the use of immunizing agents. In addition, under 42 U.S.C. 1396s, 
the committee is mandated to establish and periodically review and, as 
appropriate, revise the list of vaccines for administration to vaccine-
eligible children through the Vaccines for Children (VFC) program, 
along with schedules regarding dosing interval, dosage, and 
contraindications to administration of vaccines. Further, under 
provisions of the Affordable Care Act, section 2713 of the Public 
Health Service Act, immunization recommendations of the ACIP that have 
been approved by the Director of the Centers for Disease Control and 
Prevention and appear on CDC immunization schedules must be covered by 
applicable health plans.
    Matters to be Considered: The agenda will include discussions on 
adult immunization schedule, child/adolescent immunization schedule, 
influenza vaccines, anthrax vaccine, Japanese encephalitis vaccines, 
hepatitis vaccines, herpes zoster vaccines, human papillomavirus 
vaccines, mumps vaccine, pneumococcal vaccines, respiratory syncytial 
virus vaccine and immunization safety update. A recommendation vote is 
scheduled for adult immunization schedule, child/adolescent 
immunization schedule, hepatitis vaccines and herpes zoster vaccines. A 
Vaccines for Children vote is scheduled for hepatitis vaccines. Agenda 
items are subject to change as priorities dictate.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2017-19497 Filed 9-13-17; 8:45 am]